Dr. Reddy's Atorvastatin 10mg Tablets Recall: Impurities Risk
Dr. Reddy's recalls 10mg Atorvastatin tablets due to impurities that could affect safety. Affected lots from 2021 with specific NDC numbers. Consumers should contact the manufacturer for details.
Recall notice
Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 10mg Atorvastatin Calcium tablets that may contain impurities. This could pose a safety risk to users, though the exact impact isn't specified in the recall notice. Read more at govinfonow.com/recall/36127-dr-reddy-s-atorvastatin-10mg-tablets-recall-impurities-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36127-dr-reddy-s-atorvastatin-10mg-tablets-recall-impurities-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0629-2021
Cite this page
“Dr. Reddy's Atorvastatin 10mg Tablets Recall: Impurities Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/36127-dr-reddy-s-atorvastatin-10mg-tablets-recall-impurities-risk. Based on FDA recall #D-0629-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0629-2021%22&limit=1).
Why it’s dangerous
The tablets contain impurities called ATV cyclo IP and FP, which could affect safety. However, the recall notice does not specify how these impurities might impact users or the exact risk level.
Who’s affected
People who have the specific 500-count bottles with NDC 55111-121-05 and lots C905064 or C905065 from 2021 are affected. Those using prescription statins for cholesterol may be at risk.
How to tell if you have this one
Check for the NDC number 55111-121-05 on the bottle label. The affected lots are C905064 and C905065, with an expiration date of July 2021.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC number 55111-121-05 and lot numbers C905064 or C905065 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0629-2021 (June 4, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0629-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.